University of Miami: Breast Neoplasms trials

The registry lists 23 Breast Neoplasms studies with University of Miami as lead sponsor. 6 are open to participants now and 7 have results posted.

Early Phase 1 1Phase 1 1Phase 2 7Phase 4 2No phase 13(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Implementing a Digital Alcohol Intervention to Raise Women's Awareness of Alcohol-related Breast Cancer Risk During Routine Screening VisitsNot yet recruitingNCT07799467Not applicable
• BRain-AVOidant Proton Craniospinal Irradiation for Leptomeningeal Metastases From Solid Tumor MalignanciesRecruitingNCT07789912Not applicable
• Remotely-Delivered Cognitive Behavioral Stress Management for Breast Cancer (R-CBSM)RecruitingNCT07502352Not applicable
• Precise Oncology Interventions in Nutrition and Training (OnPoint)RecruitingNCT06534918Not applicable
• Application of Chinese Herbal Complementary and Alternative Medicine (CAM) to Improve Human Health and to Further Botanical and Horticultural SciencesRecruitingNCT04650256Not applicable
• SABER Study for Selected Early Stage Breast CancerRecruitingNCT04360330Not applicable
• Vinorelbine With Trastuzumab Emtansine in Pre-Treated HER2-Positive Metastatic Breast CancerTerminatedNCT02658084Phase 1/2Results posted
• Evaluation of the Use of AZD6244 to Induce Increased ER Expression and Anti-Estrogen Response in ER-Negative/Low Breast CancerCompletedNCT01313039Early Phase 1Results posted
• Nipple-Areola Complex (NAC) Irradiation After Nipple-Sparing Mastectomy and ReconstructionCompletedNCT01208974Not applicableResults posted
• Abraxane, Avastin, and Gemcitabine as First-Line Therapy for Patients With Metastatic Breast CancerCompletedNCT00503906Phase 2Results posted
• NOV-002, Doxorubicin, Cyclophosphamide, and Docetaxel in Women With Newly Diagnosed Stage II or IIIC Breast CancerCompletedNCT00499122Phase 2Results posted
• Thoracoscopic Sentinel Lymph Node Biopsy in Patients With Stage I or Stage II Breast CancerCompletedNCT00450723Not applicableResults posted
• Dose Dense Carboplatin, Taxotere and Herceptin As Primary Systemic Therapy in Breast CancerCompletedNCT00232479Phase 2Results posted
• Discontinuation of Maintenance HER-2 Directed Therapy in Long-Term Survivors of Metastatic HER-2 Positive Breast CancerActive, not recruitingNCT05959291Not applicable
• Individualized Piano Instruction (IPI) for Improving Cognition in Breast Cancer Survivors.CompletedNCT05909813Not applicable
• Levels of Circulating Tumor DNA as a Predictive Marker for Early Switch in Treatment for Patients With Metastatic (Stage IV) Breast CancerActive, not recruitingNCT05826964Phase 2
• A Novel Therapy for Breast Cancer Survivors With Genitourinary Syndrome of MenopauseActive, not recruitingNCT05812924Phase 2
• Prospective Evaluation of Targeted Axillary Dissection (TAD)CompletedNCT04998682Not applicable
• VSMART (Video-Conference Stress Management and Relaxation Training for Older Women With Breast Cancer)CompletedNCT03955991Phase 4
• Vortioxetine for MDD, Cognition, and Systemic Inflammatory BiomarkersWithdrawnNCT02637466Phase 4
• Facilitating Adjustment in Low Income Black Women With Breast CancerCompletedNCT02272335Not applicable
• Five Sessions Intervention to Facilitate Adaptation to Breast CancerCompletedNCT02103387Not applicable
• Facilitating Positive Adaptation to Breast CancerCompletedNCT01422551Phase 2